Nontuberculous mycobacteria infections of the pleura: A systematic review

Keren Bachar1, Tiberiu Shulimzon2, Michael J Segel3

  • 1Institute of Pulmonology, Sheba Tel-HaShomer Medical Center, Ramat Gan, Israel; Medical Corps, Israel Defense Forces, Israel.

Respiratory Medicine
|November 6, 2022
PubMed
Abstract

Insights

Nontuberculous mycobacterial (NTM) pleuritis is rare but serious, affecting diverse patients and often requiring surgery. These NTM pleural infections have a high mortality rate of 24% and significant complications.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Microbiology

Background:

  • Nontuberculous mycobacterial (NTM) pleuritis is an uncommon yet severe manifestation of NTM infection.
  • Existing literature consists primarily of case reports and small series, indicating a variable clinical course and high mortality rates.

Approach:

  • A systematic review was conducted, analyzing 206 cases of NTM pleural infections published in PubMed-indexed journals between 1980 and 2021.
  • Data on patient demographics, clinical presentation, microbiological findings, treatment interventions, complications, and outcomes were extracted and analyzed.

Key Points:

  • NTM pleural infections occurred in both immunocompetent and immunosuppressed individuals, with or without chronic lung disease or concurrent pulmonary NTM infection.
  • Mycobacterium avium complex was the most common pathogen (65%).
  • High complication rates included pneumothorax (40%), empyema (16%), and broncho-pleural fistula (16.5%), with a 24% mortality rate.

Conclusions:

  • NTM pleural infections present a significant clinical challenge with a poor prognosis.
  • Effective management often necessitates a combination of anti-NTM chemotherapy, pleural effusion drainage, and surgical interventions.
  • The high incidence of complications underscores the need for prompt diagnosis and aggressive treatment strategies.

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
303
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
412
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
186
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
278
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
359
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
248